BioSyent Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was CAD 8.87 million compared to CAD 6.79 million a year ago. Net income was CAD 2.35 million compared to CAD 1.45 million a year ago. Basic earnings per share from continuing operations was CAD 0.199 compared to CAD 0.119 a year ago. Diluted earnings per share from continuing operations was CAD 0.195 compared to CAD 0.116 a year ago.
For the nine months, sales was CAD 23.32 million compared to CAD 20.46 million a year ago. Net income was CAD 5.01 million compared to CAD 4.26 million a year ago. Basic earnings per share from continuing operations was CAD 0.417 compared to CAD 0.344 a year ago. Diluted earnings per share from continuing operations was CAD 0.41 compared to CAD 0.338 a year ago.